Menu principal

A banner year for new drugs

Last year was a high-water mark for drug approvals, with the U.S. Food & Drug Administration green-lighting 46 new molecular entities. By mid-June, FDA had given its nod to as many new molecules as were approved in all of 2016. » Veja mais...